retatrutide autoimmune Lilly Prepares for FDA Filing Following Additional Phase 3 Data in Diabetes, CVD Retatrutide (LY3437943) | GCGR/GIPR/GLP-1R Agonist
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1



























